Back to search results
NCT05045222

Economic and Clinical Outcomes of (Whole Exome) Sequencing in Tapestry

Enrolling by Invitation
Not specifiedAges 18+Observational
Mayo Clinic
~100,000 participants
Updated 2026-04-20 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in quality of life measured through adjusted years.
Measured over Every 12 months for 5 years after enrollment.
+3 more outcomes measured

Conditions

Health Care Utilization

Explore related trials

Genetic Disorder

Where it's being run

2 sites across 2 states
Arizona1
Minnesota1

Study leadership

  • Niloy Jewel Samadder, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Tapestry patients who have received genetic results, regardless of positive or negative testing results.
Age of 18 and older.
Patients with an established Mayo Clinic provider prior to their enrollment in Tapestry.

Exclusion

Individuals less than 18 years old.
Patients without capacity to consent (i.e., needing legal authorized representatives).
Prisoners.
Subjects eligible for chart review, without a Minnesota Research Authorization on record.

What this trial measures

  • Change in quality of life measured through adjusted years.Every 12 months for 5 years after enrollment.

    Measuring quality of life through adjusted years due to learning Tapestry test results.

  • Disease incidence measured by disease count per 100 participants.12 months

    Number of disease incidences per 100 participants.

  • Change in utilization measured by total number of office visits, hospital stays, ER visits, and length of visits.Every 12 months for 5 years after enrollment.

    Composite of: Number of Office-based visits. Number of Hospital stays and length of visits. Number of ER visits.

  • Change in costs measured by disease related and all-cost related costs.Every 12 months for 5 years after enrollment.

    Cost Composite of: Disease-related costs. Disease-related costs by utilization category. All-cause costs. All-cause costs by utilization category.